Jpmorgan Chase & CO Scholar Rock Holding Corp Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 38,726 shares of SRRK stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,726
Previous 38,347
0.99%
Holding current value
$1.67 Million
Previous $319,000
2.82%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding SRRK
# of Institutions
175Shares Held
75.6MCall Options Held
585KPut Options Held
862K-
Siren, L.L.C. New York, NY11.3MShares$487 Million4.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.65MShares$374 Million0.01% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.79MShares$293 Million31.52% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$245 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA5.24MShares$226 Million2.74% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $2.23B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...